AntiCoagAF
AntiCoagAF is a clinical reference application for medical practitioners, providing side-by-side anticoagulant data and dosing calculators on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual creatinine clearance calculations and cross-referencing anticoagulant protocols during patient consultations.
For Medical practitioners requiring rapid clinical reference for stroke prevention in patients with non-valvular atrial fibrillation.
What does it look like?
Key features
Side-by-side clinical data for warfarin and DOACs, serving as a brand authority lever for the developer.
Automated creatinine clearance calculation, acting as a retention lever for repeat usage during consultations.
Reference guides for peri-operative management and stroke reversal, reinforcing professional adoption.
How much does it cost?
The paid-upfront model at $1.99 allocates all proceeds to stroke research, prioritizing brand authority over recurring revenue.
Velocity
Dormant developmentperformanceShow more...
AntiCoagAF has been inactive for 549 days, indicating a complete cessation of development. The last release provided only minor bug fixes and compatibility updates for iOS 16. There is no evidence of ongoing maintenance, new feature development, or live operations. The project appears to be in a zombie state.
Who built it?
CereScape Pty
6 apps tracked · Medical
TestWorks
TowerOfLondon
NuCog
SpaceChaos
EyeMateUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for AntiCoagAF
How's the Medical market?
AntiCoagAF operates as a niche medical reference tool with no recent updates in over 500 days. The lack of active development limits its competitive standing against institutional medical software.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for AntiCoagAF
Where is it heading?
The medical reference market is shifting toward integrated, cloud-based platforms that provide real-time updates to clinical protocols. AntiCoagAF's current static model leaves it exposed to obsolescence, which will likely lead to a decline in professional adoption unless the development cadence is restored.
- The 18-month update gap suggests the app is in maintenance mode, which erodes its value as a reliable clinical reference tool.
The SWOT
- Cookcroft-Gault calculator provides immediate clinical utility
- Transition to dynamic guideline updates for professional relevance
Next best moves
Audit clinical guidelines because the 18-month update gap risks providing outdated stroke prevention data → restore professional trust.
+ 1 more prioritized moveThe counter-intuitive read
The app's static nature is a liability in medicine…
Read the full takeBottom line
Transitioning AntiCoagAF to a dynamic, updated clinical resource would address the stagnation risk, ensuring the tool remains a reliable reference for practitioners rather than a legacy artifact.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated